Actions of drugs pertinent to their abuse: Targeting subjective, discriminative, and reinforcing effects for evaluation of potential substance-use therapies

Pharmacology and Treatment of Substance Abuse: Evidence- and Outcome-Based Perspectives

Volumn , Issue , 2013, Pages 25-40

  Cooper, Ziva D ^a   Comer, Sandra D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84921308942     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203893357     Document Type: Chapter

References (26)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed., pp. 181–183). Washington, DC: American Psychiatric Press.
2. Comer, S. D., Ashworth, J. B., Foltin, R. W., Johanson, C. E., Zacny, J. P., & Walsh, S. L. (2008). The role of human drug self-administration procedures in the development of medications. Drug and Alcohol Dependence, 96, 1–15.
3. Comer, S. D., Collins, E. D., & Fischman, M. W. (2001). Buprenorphine sublingual tablets: Effects of IV heroin self-administration by humans. Psychopharmacology, 154, 28–37.
4. Comer, S. D., Sullivan, M. A., & Hulse, G. K. (2007). Sustained-relase naltrexone: Novel treatment for opioid dependence. Expert Opinion on Investigating Drugs, 16, 1285–1294.
5. Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., et al. (2006). Injectable, sustained-release naltrexone for the treatment of opioid dependence: A randomized, placebo-controlled trial. Archives of General Psychiatry, 63, 210–218.
6. Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O’Brien, C. P. (2005). A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology, 30, 205–211.
7. Deneau, G., Yanagita, T., & Seevers, M. H. (1969). Self-administration of psychoactive substances by the monkey. Psychopharmacologia, 16, 30–48.
8. Fryer, J. D., & Lukas, R. J. (1999). Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. Journal of Pharmacology and Experimental Therapeutics, 288, 88–92.
9. Galantar, M., & Kleber, H.D. (2004). Textbook of Substance Abuse Treatment (3rd ed.,). Washington, DC: American Psychiatric Press.
10. Grabowski, J., Rhoades, H., Silverman, P., Schmitz, J. M., Stotts, A., Creson, D., et al. (2000). Risperidone for the treatment of cocaine dependence: Randomized, double-blind trial. Journal of Clinical Psychopharmacology, 20, 305–1036.
11. Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors, 29, 1439–1464.
12. Griffiths, R. R., Bigelow, G. E., & Liebson, I. A. (1986). Human coffee drinking: Reinforcing and physical dependence producing effects of caffeine. Journal of Pharmacology and Experimental Therapeutics, 239, 416–425.
13. Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J., Bennett, A., Zubaran, C., et al. (2004). Marijuana withdrawal in humans: Effects of oral THC or divalproex. Neuropsychopharmacology, 29, 158–170.
14. Haney, M., & Spealman, R. (2008). Controversies in translational research: Drug self-administration. Psychopharmacology, 199, 403–419.
15. Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology, 141, 395–404.
16. Hart, C. L., Haney, M., Vosburg, S. K., Rubin, E., & Foltin, R. W. (2008). Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology, 33, 761–768.
17. Karila, L., Gorelick, D., Weinstein, A., Noble, F., Benyamina, A., Coscas, S., et al. (2008). New treatments for cocaine dependence: A focused review. International Journal of Neuropsychopharmacology, 11, 425–438.
18. Lile, J. A., Stoops, W. W., Vansickel, A. R., Glaser, P. E., Hays, L. R., & Rush, C. R. (2005). Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology, 30, 2103–2114.
19. Loebl, T., Angarita, G. A., Pachas, G. N., Huang, K. L., Lee, S. H., Nino, J., et al. (2008). A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent men. Journal of Clinical Psychiatry, 69, 480–486.
20. Nides, M. (2008). Update on pharmacologic options for smoking cessation treatment. American Journal of Medicine, 121, S20–31.
21. Racz, I., Schürmann, B., Karpushova, A., Reuter, M., Cichon, S., Montag, C., et al. (2008). The opioid peptides enkephalin and beta-endorphin in alcohol dependence. Biological Psychiatry, 64, 989–997.
22. Rush, C. R., Stoops, W. W., Hays, L. R., Glaser, P. E., & Hays, L. S. (2003). Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. Journal of Pharmacology and Experimental Therapeutics, 306, 195–204.
23. Stoops, W. W., Lile, J. A., Glaser, P. E., & Rush, C. R. (2005). Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology, 13, 56–64.
24. Sullivan, M. A., Vosburg, S. K., & Comer, S. D. (2006). Depot naltrexone: Antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology, 189, 37–46.
25. Tiihonen, J., Kuoppasalmi, K., Fohr, J., Tuomola, P., Kuikanmaki, O., Vorma, H., et al. (2007). A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. American Journal of Psychiatry, 164, 160–162.
26. Weeks, J. R., & Collins, R. J. (1964). Factors affecting voluntary morphine intake in self-maintained addicted rats. Psychopharmacologia, 6, 267–279.